Search


About Us


The University of Washington Department of Radiation Oncology is led by innovators and visionaries in cancer care.

 
About Us Table of Contents


A Brief History of Excellence

The University of Washington School of Medicine Department of Radiation Oncology was formed in 1979, an amalgam of three divisions: radiation oncology, radiation biology and medical physics.  The Department’s research and innovation, however, had been established years before the department. Following funding by the National Institutes of Health, in the early 1970’s, to study cyclotron-generated fast neutron beams.

Today, the three divisions remain; we’ve added a fourth division, radiation chemistry, and the studies on the Cyclotron led to the establishment of its own center, including the UW Medical Cyclotron Facility.  The education program has grown also. It includes accredited residency programs in both medical radiation oncology (physicians) and medical physics (physicists). It also includes two newly established medical fellowships in stereotactic radiation therapy and proton therapy. Lastly there are several post-doctoral research positions throughout the program.

The Department has 33 physician faculty, 33 physicists, 3 research faculty, and 12 ARNP/PA-C faculty.  The training programs include 10 radiation oncology residents, 4 medical physics residents, and several postdoctoral scholars. Graduate students also may participate in various research projects in radiation biology, molecular medicine, medical physics, and radiation chemistry.

The UW Department of Radiation Oncology is committed to fulfilling, specific to radiation oncology, UW Medicine’s mission to improve the health of the public by:

  • Advancing medical knowledge;
  • Providing outstanding primary and specialty care to the people of the region;
  • Preparing tomorrow’s physicians, scientists, and other health professionals; and
  • Continuing the legacy of the UW School of Medicine, which is widely known for high-quality, cost-effective education.

A core value for the department is to bring an innovative, caring, comprehensive and collaborative approach to each of our service areas: Clinical Care, Education, and Research.


Diversity Statement

For the University of Washington Department of Radiation Oncology – diversity, equity, and inclusion (DEI) are core values and mission priorities. Our work begins with the acknowledgement of the land we occupy today as the traditional home of the Tulalip, Muckleshoot, Duwamish and Suquamish tribal nations. This is followed by acceptance and celebration of the differences represented through the many diverse, black, indigenous, and/or people of color (BIPOC) communities that surround us. We recognize that we are bound together in a collective experience and that our actions impact all in our community. Focus on the lives of the most marginalized groups amongst us, subsequently creating conditions of equity, justice, and excellence for all. In our department, DEI is integral to excellence and it is our social responsibility to create actionable steps to create positive change. Only then can we truly help and subsequently improve the health of all people.


Clinical Care

We have explored and invested in advanced radiation therapy technologies.  We are the only radiation oncology facility in North America which offers the widest range of radiation therapy modalities. We go beyond the commonly used Photon and Electron radiation, to offer all modalities, concluding Photon, Electron, Neutron and Proton to our patients.

  • Photon – uses x-rays or gamma rays that come from a special machine called a linear accelerator (linac).
  • Electron  which can be used on X-ray radiation resistant tumors.
  • Neutrons – which have a higher effectiveness against certain types of cancer.
  • Protons – which have a unique ability to better protect normal tissues near the tumor from the radiation beam.

With our talented, specialized team of physicians and providers, we offer a complete spectrum of radiation therapy options. This expands to a wide range of cancers, including extremely rare cancer types.

The University of Washington is recognized as one of the country’s premier cancer centers.  We are a member institution of the National Comprehensive Cancer Network (NCCN). Our faculty members contribute to NCCN guidelines. We are affiliated with the Fred Hutchinson Cancer Center, which pioneered bone marrow transplantation and whose faculty have won three Nobel prizes.

UW Medicine, together with Fred Hutch and Seattle Children’s form the only NCI-designated Comprehensive Cancer Center in the Northwest. This group of organizations is one of the top-funded cancer centers in the country.


Education

The goal of our educational programs is to train future leaders in the field of radiation oncology and medical physics.  Residents receive outstanding training in clinical radiation oncology, treatment planning, radiation physics, and radiobiology. Training enables graduates to provide comprehensive patient care and QA activities.  All residents conduct substantive research in clinical radiation oncology, translational science, education, and health services, including safety and quality improvement.  All faculty actively participate in the education program.

Residents rotate through several sites in the UW Medicine system and receive clinical training in all aspects of radiation oncology.  They become adept in diverse radiation therapy modalities, including photons, protons, neutrons, electrons, low dose rate and high dose rate brachytherapy, stereotactic radiosurgery with the Gamma Knife, stereotactic body radiation therapy, intraoperative radiation therapy using a Mobetron unit, and intravascular therapy.


Research

The department has active research programs in particle therapy, integration of advanced imaging into radiation therapy practice, fundamental radiation biology, and medical physics topics. Some medical physics topics include Monte Carlo, multi-objective optimization, tumor response modeling, synthetic diamond detectors, smARTsKin, decision theory, patient safety, and experimental therapy proton irradiator.  In addition to these topics, we also enroll patients to trials with cooperative groups including NRG, Alliance, COG, and PCG.

With the merger in July 2023 with Fred Hutchinson Cancer Center, our bench research based on radiation oncology and in collaboration with other research divisions at Fred Hutch will expand our research program even further in the future.


Staff

In addition to our faculty, Radiation Oncology at UW School of Medicine and Fred Hutch, is fortunate to have resources of dedicated and highly experienced professionals. This team reaches throughout all areas of our patient care, research and teaching missions.   We have a large group of clinical research coordinators, cyclotron engineers, laboratory technicians, experts in grants, contracts and finance, IT support, skilled clinical care teams and collaborative administrative staff.  Interested in joining the team? Please visit our careers page.